Compare DLHC & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DLHC | CSBR |
|---|---|---|
| Founded | 1969 | 1985 |
| Country | United States | United States |
| Employees | 2300 | N/A |
| Industry | Business Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.8M | 82.7M |
| IPO Year | 2012 | 2015 |
| Metric | DLHC | CSBR |
|---|---|---|
| Price | $6.23 | $5.99 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 7.8K | 5.7K |
| Earning Date | 05-07-2026 | 06-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 161.11 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $41,923,000.00 | $2,900,000.00 |
| Revenue This Year | N/A | $4.84 |
| Revenue Next Year | $0.05 | $11.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 2.57 | N/A |
| 52 Week Low | $2.72 | $5.50 |
| 52 Week High | $8.09 | $10.25 |
| Indicator | DLHC | CSBR |
|---|---|---|
| Relative Strength Index (RSI) | 58.75 | 49.47 |
| Support Level | $5.56 | N/A |
| Resistance Level | $6.88 | $6.24 |
| Average True Range (ATR) | 0.25 | 0.24 |
| MACD | 0.02 | 0.07 |
| Stochastic Oscillator | 100.00 | 71.43 |
DLH Holdings Corp delivers health and readiness solutions for federal government customers through digital transformation and cyber security, science research and development, and systems engineering and integration. It provides technology-enabled business process, program management, and digital transformation solutions to U.S. government agencies, focusing on large-scale, technology-powered health and defense initiatives for agencies including HHS, VA, DoD, and their sub-agencies. Its revenues come from technology-enabled business process outsourcing, program management solutions, and public health research and analytics under time-and-materials, cost-reimbursable, and firm-fixed-price contracts.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.